Eyetelligence, an Australian-based innovator in AI-powered healthcare solutions, will be showcase its eye screening software at O=MEGA23.
The company’s advanced AI technology analyses full-colour fundus images to screen for referable eye diseases including glaucoma, DR, and AMD. Additionally, the technology can screen for cardiovascular diseases and provide a risk assessment profile.
O=MEGA23 attendees are invited to the company’s booth (B12) to go “Eye to Eye with AI” and immerse themselves in a firsthand experience of the groundbreaking software.
“Discover how our technology enhances accuracy, speed, and accessibility in eye screening. Join us at O=MEGA23 to witness the future of eye care. Together, let’s shape a brighter vision for global healthcare,” the company said.
To secure an appointment, click here.
